Prestige Consumer Healthcare
174 hedge funds and large institutions have $1.77B invested in Prestige Consumer Healthcare in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 76 reducing their positions, and 22 closing their positions.
1.43% more ownership
Funds ownership: 103.79% → 105.22% (+1.4%)
3% less capital invested
Capital invested by funds: $1.82B → $1.77B (-$52.5M)
5% less funds holding
Funds holding: 183 → 174 (-9)
22% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 76
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
94% less call options, than puts
Call options by funds: $181K | Put options by funds: $3.11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.1M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$15.3M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$12.5M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$11.8M |
| 2 |
AA
Ancient Art
Austin,
Texas
|
-$8.85M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.33M |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.56M |
| 5 |
Goldman Sachs
New York
|
-$5.79M |
PBH Hedge Fund Activity: Q3 2014 in Review
174 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2014, worth a combined $1.77B — down 2.9% from $1.82B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of PBH and 15 opened new positions — a net loss of 7 holders — while 76 trimmed existing stakes and 59 added.
The largest buyer was Fidelity Investments, adding an estimated $30.6M. The largest seller was Norges Bank, cutting an estimated $11.8M.
- 174 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2014, down from 183 in Q2 2014.
- Funds reported $1.77B of Prestige Consumer Healthcare stock for Q3 2014, down 2.9% quarter-over-quarter.
- 15 funds opened new Prestige Consumer Healthcare positions in Q3 2014 and 22 closed out, a net change of -7 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2014 was Fidelity Investments, an estimated $30.6M added.
- The largest Prestige Consumer Healthcare seller in Q3 2014 was Norges Bank, an estimated $11.8M sold.
Based on aggregated 13F filings for Q3 2014.